Skip to content

Press needle Therapy Combined with Sensory Integration Training in Children with Mild to Moderate Tic Disorders

Press needle Therapy Combined with Sensory Integration Training in Children with Mild to Moderate Tic Disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001272
Enrollment
Unknown
Registered
2025-06-26
Start date
2021-08-01
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tic Disorders

Interventions

PNT + SIT Group:Press needle therapy applied to standardized auricular points plus sensory integration training 3x/week for 12 weeks
Medication Control Group:Oral tiapride hydrochloride, titrated up to 600 mg/day.
SIT Group:Sensory integration training 3x/week for 12 weeks only

Sponsors

Luohu District Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 18 Years

Inclusion criteria

Inclusion criteria: Children aged 3-18 years were eligible if they met the following inclusion criteria: (1) a dual-confirmed diagnosis of TD based on DSM-5 criteria and TCM classification (e.g. "slow convulsive wind" or "liver wind syndrome"); (2) mild-to-moderate symptoms defined as Yale Global Tic Severity Scale (YGTSS) =35); (3) normal hepatic renal and neurophysiological function at baseline; (4) no prior treatment for TD or completion of a =2-week washout period; and (5) provision of informed consent and willingness to adhere to the study protocol.

Exclusion criteria

Exclusion criteria: Exclusion criteria included: (1) secondary tic-like symptoms due to organic brain disorders; (2) comorbid neurodevelopmental disorders or major organ dysfunction; (3) known allergies to stainless steel or tiapride hydrochloride; and (4) participation in other clinical trials during the study period.

Design outcomes

Primary

MeasureTime frame
Yale Global Tic Severity Scale (YGTSS) from baseline to Week 12;Traditional Chinese medicine syndrome scores;

Secondary

MeasureTime frame
Incidence of adverse events;Clinical response rate;

Countries

China

Contacts

Public ContactPeng Fan

Luohu District Hospital of Traditional Chinese Medicine

15986701789@163.com15986701789

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026